SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001085037-21-000101
Filing Date
2021-11-30
Accepted
2021-11-30 13:50:07
Documents
5
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k113021.htm 6-K 6819
2 EXHIBIT 99.1 - FINANCIAL STATEMENTS ex99_1.htm EX-99.1 484050
3 EXHIBIT 99.2 - MD&A ex99_2.htm EX-99.2 261939
4 EXHIBIT 99.3 - CEO CERTIFICATION ex99_3.htm EX-99.3 7834
5 EXHIBIT 99.4 - CFO CERTIFICATION ex99_4.htm EX-99.4 7796
  Complete submission text file 0001085037-21-000101.txt   769771
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 211459112
SIC: 2836 Biological Products, (No Diagnostic Substances)